j.vogel

TL2 Moderator · Nantes

Contributes reviews on supplier material. Based in Nantes.

Joined 24 December 2024 · last posted 1d

80 posts, newest first. Showing up to 150.

[2026 update] Antibiotics and a course of something with delayed emptying Replied, post #96 · Practice › Interactions · 27 Jul 2026 · 0 likes post #95 is right about the mechanism and I think understates the practical bit. For anyone arriving from a search: the marked solution above is the direct answer, and…
A structured critique template this community uses — a second dataset Replied, post #48 · Evidence › Study critique · 24 Jul 2026 · 0 likes Defending a paper against criticism: if the authors respond, they might clarify something the paper explained poorly. Their response might also miss your point. Either…
Rotating between abdomen, thigh and upper arm: absorption differences — one year on Replied, post #99 · Practice › Administration · 21 Jul 2026 · 15 likes This follows post #96 rather than contradicting it. Injection discomfort: comes from needle gauge (finer = less discomfort), volume (smaller = less discomfort),…
What a certificate commits its issuer to Replied, post #54 · Analytics › COA interpretation · 18 Jul 2026 · 0 likes When a document puts the specification in the result column, it has told you the release criterion, not the measurement. Those are different claims and the second is…
Aggregate verification data across the directory, with caveats Replied, post #52 · Sourcing › Independent verification · 17 Jul 2026 · 30 likes How to submit a sample: contact the service directly. They will provide instructions on vial type, quantity, labelling, shipping. Following their instructions exactly…
Selection into a registry and what it does to the estimate — a second dataset Replied, post #19 · Evidence › Study critique · 15 Jul 2026 · 4 likes Generalisability: do the inclusion/exclusion criteria narrow the population so much that results do not apply to real people asking about it? This is a fair criticism…
What a reversed-phase purity number actually is Replied, post #42 · Analytics › HPLC & UHPLC · 10 Jul 2026 · 18 likes Gradient slope is the single biggest driver of apparent purity differences. A shallower gradient over a longer run resolves more impurities and gives a higher purity…
Peak-to-trough ratio at steady state for a weekly agent — the long version Replied, post #45 · Pharmacology › Pharmacokinetics · 8 Jul 2026 · 0 likes Accumulation at steady state: with a week-long half-life, steady-state concentration is reached around 4 to 5 half-lives (about 4 to 5 weeks). Before that,…
[2026 update] Interpreting a result that disagrees with the supplier's certificate Replied, post #73 · Sourcing › Independent verification · 8 Jul 2026 · 8 likes Worth separating two things that post #69 runs together. Two things before anyone answers the substance. First, the context in the first post is clear and specific.…
Micro-titration: a disputed topic, argued properly — one year on Replied, post #56 · Practice › Dosing & titration · 29 Jun 2026 · 0 likes How the published trials escalated: they used specific step sizes and intervals. The STEP programme used a particular cadence; the SURPASS and SURMOUNT programmes used…
Publication patterns in the BPC-157 literature, examined Replied, post #21 · Compounds › Repair & healing peptides · 25 Jun 2026 · 0 likes This follows post #18 rather than contradicting it. Why plausible mechanism is not evidence of effect: a mechanism that is chemically or biologically plausible can fail…
Coming back to: Lateral-flow and colorimetric approaches: the specificity problem Replied, post #56 · Analytics › Home & field testing · 23 Jun 2026 · 7 likes post #55 answers the question as asked. The question underneath it is different. Colorimetric tests: colour intensity correlates with concentration, but the…
Racemisation and why it is invisible to a mass measurement Replied, post #21 · Analytics › Impurities & related substances · 9 Jun 2026 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
Second pass at: A pooled estimate that changed when one trial was added Replied, post #21 · Evidence › Meta-analyses · 4 Jun 2026 · 28 likes post #20 answers the question as asked. The question underneath it is different. Study quality and weighting: some meta-analyses weight all studies equally; others…
An 18-month record including the parts that went badly Replied, post #26 · Outcomes › Progress reports · 27 May 2026 · 4 likes This follows post #23 rather than contradicting it. Protein intake and resistance training: both self-reported and therefore optimistic in most reports. Recording them…
Private prescribing in the UK: what is actually involved Replied, post #22 · Regional › UK & Ireland · 24 May 2026 · 2 likes Regional variation in NHS: access varies dramatically by region depending on local commissioning decisions and specialist service availability. Postcode determines…
The best-written scientific paper you have read Replied, post #59 · Lounge › Off topic · 22 May 2026 · 2 likes Science communication: if you come across an interesting science paper or article about peptides or metabolism, sharing it and discussing the idea is on-topic.
Revisiting: The arithmetic of an intermediate dose between two label steps Replied, post #23 · Practice › Dosing & titration · 17 May 2026 · 25 likes Coming back to post #21, because the follow-up matters more than the original answer. Two things before anyone answers the substance. First, the context in the first…
Tracking intake honestly when appetite is absent Replied, post #23 · Nutrition & Training › Protein & intake · 12 May 2026 · 23 likes Eating anything at all: on substantial appetite suppression, eating enough total calories to maintain lean mass is the priority. Protein comes second to total intake.
A site rotation scheme that is easy enough to actually follow Replied, post #59 · Practice › Administration · 9 May 2026 · 3 likes On post #55 — agreed on the reasoning, with one qualification. Angle of injection: 90 degrees into pinched tissue ensures subcutaneous placement. It is not always…
Type 2 diabetes and the largest part of the evidence base Replied, post #78 · Clinical › Comorbidities · 22 Apr 2026 · 0 likes Hepatic steatosis and MASH: a phase 2 trial in semaglutide for steatohepatitis showed resolution was more frequent on treatment. Histological resolution is a surrogate…
Second pass at: The storage lookup and where its data comes from Replied, post #8 · Data & Tools › Calculators · 21 Apr 2026 · 15 likes On post #4 — agreed on the reasoning, with one qualification. Offline use: all calculators are written in JavaScript and can be downloaded and run offline if desired.…
Second pass at: Robustness: the parameters worth deliberately varying Replied, post #66 · Analytics › Method validation · 20 Apr 2026 · 6 likes Worth separating two things that post #62 runs together. Two things before anyone answers the substance. First, the context in the first post is clear and specific.…
Reconstitution volumes that produce round numbers, tabulated Replied, post #94 · Practice › Reconstitution · 18 Apr 2026 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
A plateau that disappeared when I changed how I measured — the long version Replied, post #21 · Outcomes › Progress reports · 29 Mar 2026 · 1 like Longitudinal report with the method stated: same scale, same time of day, same conditions. A scale is a tool; use the same one each time. Consistency matters more than…
Coming back to: Training through a dose escalation week Replied, post #62 · Nutrition & Training › Resistance training · 26 Mar 2026 · 22 likes Worth separating two things that post #58 runs together. Adaptation and plateau: if strength does not change for weeks, that is stability, not backsliding. Expecting…
Nausea profile of amylin analogues compared with GLP-1 agonists Replied, post #66 · Compounds › Cagrilintide & amylin analogues · 15 Mar 2026 · 9 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
Measurement error in a self-reported exposure Replied, post #52 · Evidence › Study critique · 24 Feb 2026 · 23 likes What makes a methodological criticism substantive: it identifies a specific feature of the design that materially affects what the paper can conclude. "Small sample…
Revisiting: Journal club: SURMOUNT-1, read without the press release Replied, post #15 · Evidence › Journal club · 6 Feb 2026 · 10 likes TRIUMPH (ongoing): Retatrutide phase 3. No results yet. Nothing should be attributed to it because it has not finished. When it does, this discussion will return to it.
Non-inferiority margins: how they are chosen and how they are abused Replied, post #38 · Evidence › Trials · 22 Jan 2026 · 18 likes Multiplicity and multiple comparisons: if a trial tests many hypotheses, the chance of a false positive on at least one by random chance increases. This is why…
Second pass at: Pregnancy and pregnancy planning: contraindication and washout Replied, post #36 · Clinical › Special populations · 22 Jan 2026 · 2 likes Older adults: sarcopenia risk is higher, polypharmacy is common, and the clinical trials did not enroll many people over 75. Extrapolating to very old people is…
About the Method validation category Replied, post #5 · Analytics › Method validation · 16 Jan 2026 · 32 likes Why two laboratories may disagree: after validating the same method, they may still report different purity on the same sample due to integration differences, column…
Temperature logging at home: what is worth the effort Replied, post #3 · Practice › Storage & stability · 10 Jan 2026 · 11 likes Worth separating two things that the opening post runs together. Protecting from light: amber vials or opaque containers reduce light exposure. If you are storing for…
Filter needles: when they help and what they cost you Replied, post #12 · Devices › Syringes & needles · 26 Dec 2025 · 19 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
[2026 update] Conference abstracts as evidence: the weakest common citation Started this topic · Evidence › Preprints · 7 Dec 2025 · 21 likes Conference abstracts as evidence: the weakest common citation — setting out what I have, and where I think it stops being reliable. Comparing STEP 4 ( JAMA , 2021) with…
Follow-up: Constipation management, with a dietitian's contribution Replied, post #15 · Practice › Side effects · 1 Nov 2025 · 0 likes This follows post #12 rather than contradicting it. For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add…
Availability by country, dated, with primary sources Replied, post #40 · Access › International · 31 Oct 2025 · 0 likes This follows post #37 rather than contradicting it. Regulatory position dates: a regulatory position is only current as of when it was written. Rechecking is prudent,…
Follow-up: The lowest dose that does anything: is that a real question? Replied, post #67 · Practice › Dosing & titration · 24 Oct 2025 · 1 like On post #63 — agreed on the reasoning, with one qualification. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly…
Sleep tracking data and its considerable limitations Replied, post #46 · Wellbeing › Sleep · 21 Oct 2025 · 19 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
Payment mechanics and the recovery options that do not exist Replied, post #24 · Sourcing › Payments · 19 Oct 2025 · 11 likes This follows post #21 rather than contradicting it. Bank transfer and finality: once a bank transfer is sent, it is final. The money is gone. There is no recourse with…
[2026 update] Does dual agonism explain the effect size, or is it dose? Replied, post #45 · Compounds › Tirzepatide · 15 Oct 2025 · 0 likes This follows post #42 rather than contradicting it. Mass and charge states: tirzepatide is about 4813.5 Da and on an electrospray instrument you would expect to see…
Request: a diff view for wiki revisions — the long version Replied, post #54 · Meta › Feature requests · 11 Oct 2025 · 4 likes Tradeoffs: every feature has a cost in maintenance and complexity. Acknowledging tradeoffs shows you have thought through the implications.
Pinch or no pinch, and how needle length changes the answer Replied, post #102 · Practice › Administration · 9 Oct 2025 · 0 likes Angle of injection: 90 degrees into pinched tissue ensures subcutaneous placement. It is not always necessary and shallower angles can work, but 90 degrees into a small…
High-resolution MS on aggregates and what it can see Replied, post #54 · Analytics › Mass spectrometry · 28 Aug 2025 · 29 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
A parcel that arrived warm: a decision process, not a verdict Replied, post #8 · Practice › Storage & stability · 21 Aug 2025 · 29 likes Published stability data applies specifically to the formulation studied, under the specific conditions stated. It does not automatically transfer to something…
A comparison of home results against a laboratory result on the same vial Replied, post #24 · Analytics › Home & field testing · 12 Aug 2025 · 18 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
Managing an unplanned gap in supply — what changed since Replied, post #33 · Access › Shortages · 7 Aug 2025 · 29 likes On post #29 — agreed on the reasoning, with one qualification. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what…
Journal club: indirect comparison between two programmes, defended and attacked — one… Replied, post #26 · Evidence › Journal club · 4 Aug 2025 · 0 likes Coming back to post #24, because the follow-up matters more than the original answer. SURMOUNT-1 (N Engl J Med 2022): Tirzepatide obesity trial. The largest mean weight…
Travel coolers and how long they really hold Replied, post #8 · Devices › Cold chain · 31 Jul 2025 · 2 likes Worth separating two things that post #4 runs together. Travel with medication: carrying a vial across borders requires planning if temperatures will exceed the range…
A checklist for reading a certificate in under two minutes — does this still hold? Replied, post #21 · Analytics › COA interpretation · 10 Jul 2025 · 0 likes When a document puts the specification in the result column, it has told you the release criterion, not the measurement. Those are different claims and the second is…
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #154 · Practice › Reconstitution · 4 Jul 2025 · 12 likes A vial that will not fully dissolve: check in order: is the diluent genuinely room temperature (some preservatives crystallise in cold), is the vial being warmed gently…
Interim analyses and stopping rules — does this still hold? Replied, post #11 · Evidence › Trials · 27 Jun 2025 · 23 likes I read post #9 twice before replying, because I had assumed the opposite. Dropout is information: high dropout rates can indicate tolerability problems or lower…
Follow-up: Tracking intake honestly when appetite is absent Replied, post #14 · Nutrition & Training › Protein & intake · 3 Jun 2025 · 0 likes Timing of protein: spreading protein intake across the day, with some at each meal, is more practical than trying to hit the whole target at one sitting on suppressed…
Coming back to: An 18-month record including the parts that went badly Replied, post #60 · Outcomes › Progress reports · 2 Jun 2025 · 0 likes Plateaus and resets: if weight loss stalls and then resumes, that is ordinary. It is not evidence that the medication stopped working. It is not evidence that it is…
[2026 update] Clearance pathways and what renal impairment changes Replied, post #9 · Pharmacology › Pharmacokinetics · 21 May 2025 · 5 likes Picking up post #6: that is the part I would want checked first. Half-life: semaglutide ≈ 165–184 hours (about a week). Tirzepatide ≈ 5 days. Liraglutide ≈ 13 hours.…
Critiquing an observational claim about a class effect Replied, post #3 · Evidence › Study critique · 18 May 2025 · 28 likes This follows post #2 rather than contradicting it. Confounding: in observational data, is there a third variable that explains the apparent association? In randomised…
Coming back to: What published stability data actually covers, and what it does not Replied, post #28 · Practice › Storage & stability · 25 Apr 2025 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
When "no data" is the complete and final answer Replied, post #150 · Compounds › Other compounds · 16 Apr 2025 · 3 likes When "no data" is the complete and final answer: if there is no published human data on a compound, that is the state of knowledge. Hope is not a substitute and…
Asking about a compound your prescriber has not heard of Replied, post #11 · Clinical › Prescriber conversations · 5 Apr 2025 · 29 likes Discussing side effects: be specific. "Nausea" is less useful than "I have nausea worst 24 to 36 hours after injection, severity 2 to 3 out of 4, stable over weeks".…
Certificates issued by the seller versus by a laboratory Replied, post #5 · Analytics › COA interpretation · 13 Mar 2025 · 14 likes post #4 is right about the mechanism and I think understates the practical bit. Water content (residual moisture) matters: lyophilised peptide is not dry. A few percent…
Revisiting: Bug report: the reconstitution calculator and a rounding edge case Replied, post #119 · Data & Tools › Calculators · 7 Mar 2025 · 16 likes On post #115 — agreed on the reasoning, with one qualification. Reconstitution calculator: enter vial mass, final volume target, and the calculator tells you…
Research-use-only status: what it means legally and practically — a second dataset Replied, post #87 · Compounds › Other compounds · 11 Feb 2025 · 26 likes I read post #85 twice before replying, because I had assumed the opposite. Compounds this community declines to help with, and why: there are specifics in the…
Journal club: SURMOUNT-1, read without the press release Replied, post #50 · Evidence › Journal club · 26 Jan 2025 · 6 likes This follows post #47 rather than contradicting it. I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The…
What the published dose-response for semaglutide actually looks like above 2.4 mg — a… Replied, post #18 · Compounds › Semaglutide · 5 Jan 2025 · 0 likes This follows post #15 rather than contradicting it. For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add…
[2026 update] Step therapy requirements and how to satisfy them Replied, post #102 · Access › Insurance & coverage · 3 Jan 2025 · 0 likes Coverage for weight management versus diabetes: many formularies cover these compounds for type 2 diabetes but not for weight management. The indication matters and…
SURPASS-2 and the comparator dose question that will not go away Replied, post #73 · Compounds › Tirzepatide · 7 Dec 2024 · 3 likes Half-life difference: tirzepatide is about 5 days versus semaglutide's week-long. Practically, that means steady state is reached slightly faster and the post-dose…
Time to steady state after a dose increase Replied, post #109 · Pharmacology › Pharmacokinetics · 5 Nov 2024 · 2 likes Renal clearance: these compounds are cleared partly via the kidney. In severe renal impairment, clearance is slowed and accumulation risk is higher. Dose adjustments…
Coming back to: Renal impairment: what the labelling says about dose Replied, post #13 · Clinical › Special populations · 5 Nov 2024 · 0 likes post #12 is right about the mechanism and I think understates the practical bit. Hepatic impairment: less is known about dosing in significant liver disease than in…
Anxiety in the first weeks: drug, situation, or both Replied, post #12 · Wellbeing › Mental health · 29 Oct 2024 · 5 likes Disordered eating history: a history of anorexia, bulimia, or other eating disorders changes the risk-benefit calculation. Appetite suppression might trigger relapse.…
Second pass at: Food noise reducing and the disorientation that can follow Replied, post #42 · Wellbeing › Mental health · 21 Oct 2024 · 0 likes Support and community: some people process weight change through community (online or in-person). Others prefer privacy. Knowing what you need and seeking it…
Hypertension improvement and when medication needs revisiting — a second dataset Replied, post #56 · Clinical › Comorbidities · 18 Oct 2024 · 2 likes Hepatic steatosis and MASH: a phase 2 trial in semaglutide for steatohepatitis showed resolution was more frequent on treatment. Histological resolution is a surrogate…
Second pass at: Hoarding and why it makes a shortage worse Replied, post #12 · Access › Shortages · 9 Oct 2024 · 17 likes Compounding during shortages: some jurisdictions allow pharmacy compounding when a marketed product is in shortage. That permission is jurisdiction-specific and…
Progressive overload when the scale is falling — one year on Replied, post #122 · Nutrition & Training › Resistance training · 4 Oct 2024 · 14 likes Post-weight-loss training: once weight loss is complete and energy deficit ends, training can shift to building again. The transition from preservation mode to building…
Tirzepatide storage and stability: what is published versus what is assumed — does this… Replied, post #3 · Compounds › Tirzepatide · 3 Oct 2024 · 21 likes SURPASS-2 compared tirzepatide with semaglutide 1.0 mg, the licensed diabetes dose at that time. It did not compare with semaglutide 2.4 mg, the highest approved dose.…
Reporting a discrepancy without making an allegation Replied, post #75 · Sourcing › Vendor reports · 15 Sep 2024 · 0 likes Lot matching: confirm the lot number on the certificate matches the lot number on the vial. A result from a different lot is not evidence about your vial.
Second pass at: Albumin binding and how it produces a long half-life Replied, post #3 · Pharmacology › Pharmacokinetics · 29 Aug 2024 · 0 likes Picking up post #2: that is the part I would want checked first. Hepatic metabolism: the degree to which each compound is hepatically metabolised versus renally cleared…
Correlation in a self-tracked dataset: what it can support Replied, post #121 · Research Methods › Statistics · 25 Aug 2024 · 23 likes Multiplicity and multiple comparisons: if you test many hypotheses, the chance of finding a false positive by random chance increases. That is why pre-specifying the…
Gallbladder disease risk with rapid weight loss Replied, post #3 · Clinical › Comorbidities · 22 Aug 2024 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
Second pass at: Sodium, potassium and magnesium when intake drops Replied, post #18 · Nutrition & Training › Hydration & electrolytes · 30 Jul 2024 · 17 likes Coming back to post #16, because the follow-up matters more than the original answer. Orthostatic symptoms: dizziness on standing after lying down can indicate…
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #40 · Practice › Dosing & titration · 7 Jul 2024 · 1 like post #39 answers the question as asked. The question underneath it is different. Dose equivalence between different incretin analogues is a weak concept. The molecules…